On September 17, Intel rose 4.48% in regular trading, trading at $105.495/share, with turnover of $874 million, as a confluence of positive developments lifted the stock.

On the news front, reports emerged that Intel has accelerated its 14A process node to trial production in Q1 next year, ahead of schedule. Additionally, CEO Lip-Bu Tan stated that CPU demand is extremely strong, with the company currently able to satisfy only approximately 50% of customer demand, underscoring a persistent supply-demand imbalance. Meanwhile, SK Hynix is reportedly in discussions with Intel to lease part of its Ohio fabrication facility for US-based memory chip production, though SK Hynix clarified that no plans have been finalized. Tigress Financial raised its price target on Intel to $145 from $118, maintaining a Buy rating. The average analyst target stands at $121.11.

Broader market conditions also provided a tailwind, as the Fed's 25-basis-point rate hike to 3.75%-4.00% landed in line with expectations, removing uncertainty and lifting technology stocks broadly. The semiconductor sector saw widespread gains, with Marvell Technology up 6.18%, Micron Technology up 4.33%, AMD up 3.97%, Broadcom up 2.34%, and NVIDIA up 1.94%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)